Hepatocellular carcinoma (HCC) is the seventh most common cancer worldwide and the
third most common cause of cancer-related deaths; the number of new cases per year is …

Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and its
mortality is third among all solid tumors, behind carcinomas of the lung and the colon …

Background: Potential prognostic biomarker candidates for hepatocellular carcinoma (HCC)
are abundant, but their generalizability is unexplored. We cross-validated markers of overall …

Objective: To assess the efficacy of orthotopic liver transplantation (OLT) for hepatocellular
carcinoma (HCC) and the impact of current staging criteria on long term survival. Summary …

Abstract Background & Aims Liver transplantation is the only curative intervention for
terminal liver disease. Accurate long‐term quality of life (QOL) data are required in the …

The currently available indication criteria of living donor liver transplantation (LDLT) for
patients with hepatocellular carcinoma (HCC) have high prognostic power but insufficient …

Background: Liberal acceptance criteria are used when offering liver transplantation (LTx)
for treatment of hepatocellular carcinoma (HCC) at our center. This provides a unique …

Objective: The aims of this study were to present evidence to develop and validate the
Japanese Tumor-Node-Metastasis (TNM) staging system for primary liver cancer and to …

Objective To review the preoperative and postoperative variables that predict hepatocellular
carcinoma (HCC) recurrence following orthotopic liver transplantation (OLT). Data Sources …

BACKGROUND & AIMS: The increasing incidence of hepatocellular carcinoma (HCC) in the
United States has significant health and economic consequences. Ultrasound (US) …